·07/05/08 ADAMTS13 turns 3
·07/05/08 Hypoxia-reoxygenation induces premature senescence in FA bone marrow hematopoietic cells
·07/05/08 Distinct hematopoietic progenitor compartments are delineated by the expression of aldehyde dehydrogenase and CD34
·07/05/08 p85 subunit of class IA PI-3 kinase is crucial for macrophage growth and migration
·07/05/08 The relative role of PLC and PI3K in platelet activation
·07/05/08 Young thrombocytes initiate the formation of arterial thrombi in zebrafish
·07/05/08 Thalidomide-induced antiangiogenic action is mediated by ceramide through depletion of VeGF receptors, and is antagonized by sphingosine-1-phosphate
·07/05/08 VCAM-1 expression in adult hematopoietic and nonhematopoietic cells is controlled by tissue-inductive signals and reflects their developmental origin
·07/05/08 Cleavage of ultralarge multimers of von Willebrand factor by C-terminal–truncated mutants of ADAMTS-13 under flow
·07/05/08 Cytotoxic minor histocompatibility antigen HA-1–specific CD8+ effector memory T cells: artificial APCs pave the way for clinical application by potent primary in vitro induction
·07/05/08 The role of endothelial PI3K activity in neutrophil trafficking
·07/05/08 CCR6 regulates CD4+ T-cell–mediated acute graft-versus-host disease responses
·07/05/08 A potential role for hydrocortisone in the positive regulation of IL-15–activated NK-cell proliferation and survival
·07/05/08 The cancer-testis antigens CT7 (MAGe-C1) and MAGe-A3/6 are commonly expressed in multiple myeloma and correlate with plasma-cell proliferation
·07/05/08 Balance between NF-B and JNK/AP-1 activity controls dendritic cell life and death
·07/05/08 IFN-–mediated negative feedback regulation of NKT-cell function by CD94/NKG2
·07/05/08 Lack of antigen-specific tissue remodeling in mice deficient in the macrophage galactose-type calcium-type lectin 1/CD301a
·07/05/08 In vitro and in vivo activity of ATP-based kinase inhibitors AP23464 and AP23848 against activation-loop mutants of Kit
·07/05/08 SUMO-1 conjugation selectively modulates STAT1-mediated gene responses
·07/05/08 Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA): long-term follow-up of the Northwestern University experience
·07/05/08 Aberrant mitochondrial iron distribution and maturation arrest characterize early erythroid precursors in low-risk myelodysplastic syndromes
·07/05/08 Azidothymidine inhibits NF-B and induces epstein-Barr virus gene expression in Burkitt lymphoma
·07/05/08 Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a rando
·07/05/08 Meis1 programs transcription of FLT3 and cancer stem cell character, using a mechanism that requires interaction with Pbx and a novel function of the Meis1 C-terminus
·07/05/08 AML-associated Flt3 kinase domain mutations show signal transduction differences compared with Flt3 ITD mutations
·07/05/08 HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL)
·07/05/08 NUP98-HOXD13 transgenic mice develop a highly penetrant, severe myelodysplastic syndrome that progresses to acute leukemia
·07/05/08 Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma
·07/05/08 ICAM-1 on exosomes from mature dendritic cells is critical for efficient naive T-cell priming
·07/05/08 T-cell generation by lymph node resident progenitor cells
·07/05/08 CD8–11b+ dendritic cells but not CD8+ dendritic cells mediate cross-tolerance toward intestinal antigens
·07/05/08 Arsenic suppresses gene expression in promyelocytic leukemia cells partly through Sp1 oxidation
·07/05/08 Heat shock protein 90 inhibition sensitizes acute myelogenous leukemia cells to cytarabine
·07/05/08 Superiority of thalidomide and dexamethasone over vincristine-doxorubicindexamethasone (VAD) as primary therapy in preparation for autologous transplantation for multiple myeloma
·07/05/08 Constitutively activated FGFR3 mutants signal through PLC-dependent and -independent pathways for hematopoietic transformation

1 [2] [下一页] [尾页]